H. Takahashi et al., LIPID ANALYSIS AND SURFACTANT-ASSOCIATED PROTEIN EXPRESSION IN LUNG ADENOCARCINOMA CELLS FROM PLEURAL EFFUSION, Respiration, 63(6), 1996, pp. 390-396
Primary lung adenocarcinomas originate from the progenitor cells of pe
ripheral airway cells. Alveolar type II cells and Clara cells are the
major progenitor cells of peripheral airway cells. Alveolar type II ce
lls produce a lipid-protein complex called surfactant, which contains
surfactant proteins SP-A, SP-B, SP-C and SP-D. Phosphatidylcholine (PC
) and phosphatidylglycerol (PG) are believed to be essential for the s
urfactant function. Clara cells also express SP-A, SP-B and SP-D but n
ot SP-C. In this study we examined the properties of the cancer cells
isolated from the pleural effusion of a patient with primary lung aden
ocarcinoma by analyzing lipids, proteins and mRNAs. The cancer cells,
designated as LC117 cells, were isolated from the pleural effusion of
a patient with primary lung adenocarcinoma. The percent distributions
of [C-14]-acetate incorporated into PC and PG in the cancer cells were
55.7 and 1.1%, respectively. The disaturated species in total PC was
46.2%. Immunoblotting analysis using anti-SP-D monoclonal antibody rev
ealed that the pleural effusion from a patient with lung adenocarcinom
a contained SP-D. We determined the concentrations of SP-A and SP-D by
enzyme-linked immunosorbent assay. The pleural effusions from this pa
tient and the media incubated with cancer cells exhibited significant
levels of SP-D as well as SP-A. Reverse transcriptase-polymerase chain
reaction demonstrated that the tumor cells expressed mRNAs for SP-C a
s well as the other surfactant proteins. The results demonstrate that
tumor cells from lung adenocarcinoma express all of surfactant-associa
ted proteins, indicating that LC117 cells originate from alveolar type
II cells. This study indicates that the combination of analyses of li
pids, proteins and mRNAs in the cancer cells isolated from pleural eff
usion is useful to understand the property of lung adenocarcinoma.